# FDA Inspection 1092841 - Danny H. Sugimoto, M.D. - May 23, 2019

Source: https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/d3c03542-cc19-4779-b623-e1301ba9d1a0
Source feed: FDA_Inspections

> FDA Inspection 1092841 for Danny H. Sugimoto, M.D. on May 23, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092841
- Company Name: Danny H. Sugimoto, M.D.
- Inspection Date: 2019-05-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 923844 - 2015-05-20](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/77ed0254-94df-4a88-8f6b-fdc4d7db7294)
- [FDA Inspection 926019 - 2015-05-20](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/1c72c007-ea6a-40f9-b57f-b31776fda4fa)
- [FDA Inspection 860826 - 2014-01-02](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/14769f74-884e-4b80-8f27-f0a21f01c6c2)
- [FDA Inspection 571974 - 2009-02-23](https://www.keypedia.com/records/fda_inspections/danny-h-sugimoto-md/e9f2e9f3-3a65-4f15-8e4c-080e2947ae86)

Company: https://www.keypedia.com/companies/danny-h-sugimoto-md/dc781d15-5f74-42bd-b6cc-13f572ac50b9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c